Moleculin Biotech CS (MBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MBRX | AMGN | VRTX | GILD | BMY |
| Company | Moleculin Biotech CS | Amgen Inc | Vertex Pharmaceutic | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 1.7300 | 262.48 | 401.53 | 93.00 | 57.41 |
| High | 1.8200 | 264.55 | 410.68 | 94.05 | 57.77 |
| Low | 1.6300 | 261.36 | 401.27 | 92.10 | 57.01 |
| Last | 1.8200 | 264.49 | 408.18 | 93.95 | 57.76 |
| Change | +0.0900 | +0.49 | +2.91 | +0.55 | +0.18 |
| % Change | +5.20% | +0.19% | +0.72% | +0.59% | +0.31% |
| Volume | 25,700 | 1,520,500 | 1,468,500 | 2,109,100 | 3,668,100 |
| 20-Day Average Volume | 63,915 | 5,000,690 | 1,832,675 | 7,173,320 | 11,391,425 |
| Previous Close | 1.7300 | 264.00 | 405.27 | 93.40 | 57.58 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.3135 | 272.02 | 452.00 | 92.30 | 57.87 |
| 20-Day Raw Stochastic | 20.00% | 36.88% | 30.76% | 87.27% | 53.88% |
| 20-Day Relative Strength | 38.71% | 33.45% | 33.99% | 58.19% | 54.00% |
| Weighted Alpha | -78.34 | -14.60 | -7.89 | +26.09 | +20.51 |
| Today's Opinion | 88% Sell | 88% Sell | 72% Sell | 100% Buy | 80% Buy |
| Previous Opinion | 88% Sell | 88% Sell | 72% Sell | 100% Buy | 80% Buy |
| Last Month's Opinion | 40% Sell | 40% Sell | 24% Sell | 80% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.15% since 12/17/24 | -0.55% since 12/17/24 | -13.01% since 12/17/24 | +1.24% since 12/17/24 | +0.19% since 12/17/24 |
| Low | 1.5000 on 12/23/24 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 90.27 on 12/19/24 | 56.08 on 12/20/24 |
| High | 2.1000 on 12/18/24 | 269.61 on 12/20/24 | 471.05 on 12/18/24 | 94.05 on 12/24/24 | 58.54 on 12/18/24 |
| 1-Month | |||||
| %Chg | -33.33% since 11/22/24 | -10.20% since 11/22/24 | -9.49% since 11/22/24 | +4.17% since 11/22/24 | -1.89% since 11/22/24 |
| Low | 1.5000 on 12/23/24 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 89.15 on 12/13/24 | 55.04 on 12/13/24 |
| High | 3.1000 on 12/11/24 | 297.32 on 11/25/24 | 476.46 on 12/10/24 | 94.65 on 12/11/24 | 60.68 on 11/25/24 |
| 3-Month | |||||
| %Chg | -32.34% since 09/24/24 | -20.07% since 09/24/24 | -11.84% since 09/24/24 | +12.13% since 09/24/24 | +13.39% since 09/24/24 |
| Low | 1.5000 on 12/23/24 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 81.83 on 09/26/24 | 49.11 on 09/25/24 |
| High | 3.3300 on 11/14/24 | 329.50 on 09/25/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 | 61.08 on 11/11/24 |
| 6-Month | |||||
| %Chg | -49.58% since 06/24/24 | -16.87% since 06/24/24 | -14.06% since 06/24/24 | +32.83% since 06/24/24 | +36.77% since 06/24/24 |
| Low | 1.5000 on 12/23/24 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 66.01 on 07/05/24 | 39.35 on 07/05/24 |
| High | 4.7070 on 07/18/24 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 | 61.08 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 5,807 | 142,172,096 | 105,118,176 | 117,086,688 | 117,147,504 |
| Shares Outstanding, K | 3,191 | 537,533 | 257,529 | 1,246,266 | 2,028,177 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 27,116,000,000 | 45,006,000,000 |
| Annual Net Income | -29,770,000 | 6,717,000,000 | 3,619,600,000 | 5,665,000,000 | 8,025,000,000 |
| Last Quarter Sales | 0 | 8,503,000,000 | 2,771,900,000 | 7,545,000,000 | 11,892,000,000 |
| Last Quarter Net Income | -10,590,000 | 2,830,000,000 | 1,045,400,000 | 1,253,000,000 | 1,211,000,000 |
| 60-Month Beta | 1.87 | 0.55 | 0.36 | 0.18 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | -2.09 on 11/08/24 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 | 1.80 on 10/31/24 |
| Latest Earnings Date | 11/08/24 | 02/04/25 | 02/03/25 | 02/11/25 | 02/06/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | N/A | 0.770 on 12/13/24 | 0.600 on 10/04/24 |
| Next Ex-Dividends Date | N/A | 02/14/25 | N/A | 12/13/24 | 01/03/25 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 13.74 | 0.00 | 21.08 | 49.21 |